ReviewCureus2026

Implications of Potential US FDA Approval of Psychedelics or Psychedelic-Adjacents Such as Ibogaine for Pharmacy in Japan.

Robert B RaffaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.